Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glutamate Carboxypeptidase II | 3 | 2024 | 90 | 2.280 |
Why?
|
| Antigens, Surface | 3 | 2024 | 1617 | 1.370 |
Why?
|
| Prostatic Neoplasms | 9 | 2024 | 11094 | 0.830 |
Why?
|
| Glutamates | 1 | 2022 | 384 | 0.710 |
Why?
|
| Molecular Probes | 1 | 2022 | 309 | 0.690 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2019 | 58 | 0.670 |
Why?
|
| Urea | 1 | 2022 | 449 | 0.660 |
Why?
|
| Hexokinase | 1 | 2019 | 125 | 0.650 |
Why?
|
| Lysine | 1 | 2022 | 998 | 0.560 |
Why?
|
| Prostate-Specific Antigen | 2 | 2023 | 2463 | 0.420 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2019 | 2028 | 0.360 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 3942 | 0.270 |
Why?
|
| Cell Cycle Proteins | 3 | 2022 | 3440 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2024 | 8623 | 0.240 |
Why?
|
| Prostate | 2 | 2023 | 1760 | 0.220 |
Why?
|
| Phenylthiohydantoin | 1 | 2024 | 206 | 0.210 |
Why?
|
| Receptors, Kainic Acid | 1 | 2022 | 91 | 0.190 |
Why?
|
| Molecular Conformation | 1 | 2022 | 540 | 0.180 |
Why?
|
| Neuroendocrine Tumors | 2 | 2024 | 659 | 0.180 |
Why?
|
| Nitriles | 1 | 2024 | 981 | 0.160 |
Why?
|
| Benzamides | 1 | 2024 | 1375 | 0.160 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 17089 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2022 | 2470 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 1073 | 0.140 |
Why?
|
| Taxoids | 1 | 2020 | 665 | 0.140 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2021 | 343 | 0.140 |
Why?
|
| DNA Helicases | 1 | 2022 | 854 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2022 | 3053 | 0.130 |
Why?
|
| Cell Differentiation | 3 | 2024 | 11657 | 0.130 |
Why?
|
| Disease Progression | 3 | 2022 | 13642 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2022 | 822 | 0.120 |
Why?
|
| Receptors, Androgen | 1 | 2021 | 1089 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2022 | 1927 | 0.110 |
Why?
|
| Binding Sites | 1 | 2022 | 6013 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2024 | 5330 | 0.100 |
Why?
|
| Male | 13 | 2024 | 364154 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2022 | 5388 | 0.100 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 13644 | 0.090 |
Why?
|
| Adenocarcinoma | 3 | 2024 | 6359 | 0.090 |
Why?
|
| Mice | 8 | 2024 | 81898 | 0.080 |
Why?
|
| Protein Binding | 1 | 2022 | 9326 | 0.080 |
Why?
|
| Gene Expression | 1 | 2022 | 7585 | 0.080 |
Why?
|
| Animals | 9 | 2024 | 168939 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2022 | 11062 | 0.070 |
Why?
|
| Zebrafish | 1 | 2019 | 3035 | 0.070 |
Why?
|
| Glucose | 1 | 2019 | 4340 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2329 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 6548 | 0.070 |
Why?
|
| Humans | 13 | 2024 | 766812 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9613 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4356 | 0.060 |
Why?
|
| Neuroendocrine Cells | 1 | 2024 | 61 | 0.050 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2023 | 101 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18329 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2024 | 23618 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2024 | 1206 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2024 | 751 | 0.040 |
Why?
|
| Platinum | 1 | 2020 | 219 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 789 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9546 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2021 | 670 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2024 | 2093 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 1996 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2024 | 2573 | 0.030 |
Why?
|
| Cisplatin | 1 | 2020 | 1656 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 1900 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2020 | 1405 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 2952 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2024 | 8310 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6105 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3605 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2023 | 4427 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5690 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14473 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10451 | 0.010 |
Why?
|
| Apoptosis | 1 | 2020 | 9514 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2023 | 12159 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22351 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29959 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11876 | 0.010 |
Why?
|
| Female | 1 | 2020 | 396532 | 0.000 |
Why?
|
Concepts
(81)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_